Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.

PLoS One · 2016 · PMC4723316 · PMID 26799942

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)

The placebo group showed no significant change in PCS from baseline to end-of-treatment (mean change –0.8 SEM ± 0.8 (p = 0.29)), while the omega-3 FA group showed a trend-level positive change in PCS from baseline to end-of-treatment (mean change 1.6 SEM ± 0.8 (p = 0.06)).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.